Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year earnings per share growth rate
Latest
40.00%
↑ 24% above average
Average (9y)
32.19%
Historical baseline
Range
High:71.80%
Low:-11.11%
CAGR
+6.4%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 40.00% |
| 2023 | 52.00% |
| 2022 | 58.33% |
| 2021 | 29.08% |
| 2020 | 71.80% |
| 2019 | 11.76% |
| 2018 | 10.53% |
| 2017 | 36.67% |
| 2016 | -11.11% |
| 2015 | 22.86% |